Lonza, Agennix JV talactoferrin production
X
Waste Management Expo 2020 MAR 12&13 BIEC, Bengaluru, India

Lonza, Agennix JV for talactoferrin production

6:55 AM, 13th April 2012
Lonza, Agennix JV for talactoferrin production
Rajesh Malik, Chief Medical Officer and Management Board member, Agennix.

BASEL, SWITZERLAND/MUNICH, GERMANY: Lonza and Agennix signed an agreement for the production of Agennix’s first-in-class oral dendritic cell mediated immunotherapy (DCMI), talactoferrin, currently in Phase III testing for the treatment of non-small cell lung cancer (NSCLC). Lonza will produce commercial material at its microbial manufacturing facility in Kourim, Czech Republic. This agreement initiates the process needed to ultimately seek approval for Lonza as a second manufacturer of talactoferrin after the initial commercial launch. 

“Lonza has extensive experience manufacturing biologics on a commercial scale. In anticipation of positive Phase III data and a potential product approval, it is important that we have more than one manufacturer in place to ensure we can meet anticipated commercial demand and that we have security of supply,” said Rajesh Malik, Chief Medical Officer and Management Board member, Agennix.

© WOC News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Japan, South Korea groups buy Australian mine stake for $3.67 billion

TOKYO, JAPAN: South Korean steelmaker POSCO, Japanese trading firm Marubeni and Korean conglomerate STX Corp will pay about $3.67 billion for a 30 per ...

Read more
BP to implement carbon offset programme for Fedex Envelope

LONDON, UK: Through the carbon-neutral FedEx Envelope shipping programme, FedEx will calculate the carbon dioxide released through FedEx Envelope ship ...

Read more
Enterprise, Anadarko and DCP to construct NGL pipeline in DJ Basin

HOUSTON/THE WOODLANDS, US: Enterprise Products Partners, Anadarko Petroleum Corporation and DCP Midstream, LLC announced an agreement to design and co ...

Read more
KBR gets ethylene furnace contract from INEOS

HOUSTON, US: KBR will design and construct an ethylene furnace for INEOS Olefins & Polymers, US that upon commissioning will provide the highest a ...

Read more
Dr Reddy’s Labs may seal pact with Fujifilm for Japanese JV by June

HYDERABAD, INDIA: Dr Reddy’s Laboratories, the country second largest pharma company, expects to sign a definitive agreement by June with Japan- ...

Read more
HPCL-Mittal Energy JV commissions $4 billion Bathinda refinery

NEW DELHI, INDIA: HPCL-Mittal Energy (HMEL), a joint venture of state-owned Hindustan Petroleum Corporation and steel czar Lakshmi Mittal, recently an ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X